2013
DOI: 10.1007/s00044-013-0873-0
|View full text |Cite
|
Sign up to set email alerts
|

New azetidine-3-carbonyl-N-methyl-hydrazino derivatives of fluoroquinolones: synthesis and evaluation of antibacterial and anticancer properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(12 citation statements)
references
References 12 publications
0
12
0
Order By: Relevance
“…Compound 6h showed more potency against the MCF‐7 cell line with 56% growth inhibition as compared with the standard drugs ciprofloxacin (41% growth inhibition) and SAHA (33% growth inhibition). [ 42 ]…”
Section: Therapeutic Importance Of Molecules Containing the Azetidine Heterocyclementioning
confidence: 99%
See 1 more Smart Citation
“…Compound 6h showed more potency against the MCF‐7 cell line with 56% growth inhibition as compared with the standard drugs ciprofloxacin (41% growth inhibition) and SAHA (33% growth inhibition). [ 42 ]…”
Section: Therapeutic Importance Of Molecules Containing the Azetidine Heterocyclementioning
confidence: 99%
“…However, all other compounds were less active than the standard drug SAHA in A549 and HCT‐116 cell lines and were more potent than ciprofloxacin in A549 and HCT‐116. [ 42 ]…”
Section: Therapeutic Importance Of Molecules Containing the Azetidine Heterocyclementioning
confidence: 99%
“…The fluoroquinolone series, substituted with N-(substituted azetidine-3-carbonyl)-N-methylhydrazino derivatives showed cytotoxic activity toward Breast cancer cell line, MCF-7, Colon cancer cell line, HCT-116, and Lung adenocarcinoma cell line, A549, and some of them exhibited higher activity than ciprofloxacin and the positive control drug SAHA. Compound 69 exhibited the highest activity among this series against MCF-7 breast cancer cell line with GI% range, 23-56 % at a concentration range 1-50 μM [103]. The norfloxacin analogs substituted at N-7 with benzo[d]thiazolyl moiety through butyramide linker were evaluated for the cytotoxic activities against A549, lung cancer cell line.…”
Section: Modifications Of Fluoroquinolones At 7positionmentioning
confidence: 99%
“…Some derivatives revealed an activity more than the reference drug SAHA, which was used as a positive control. Compound 13 was among the most potent derivatives and exhibited the highest activity against the breast carcinoma MCF‐7 cell line with a percent growth inhibition 23–56% at a concentration range 1–50 µM . Derivatives of ciprofloxacin and norfloxacin substituted at the piperazinyl N‐ 4 with N‐ (benzo[ d ]thiazol‐2‐yl)butyramide substituents were tested for cytotoxicity using the human lung cancer cell lines A549.…”
Section: Fluoroquinolone Derivatives With Anticancer Activitymentioning
confidence: 99%